EXPLAINER: $26B opioid settlement big step, but not the end
COLUMBUS, Ohio — A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant — but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. In West Virginia, a trial of claims brought by the city of Huntington and surrounding Cabell County against the nation’s three largest opioid distributors is scheduled to wrap up next week. Meanwhile, several California counties — including populous Los Angeles, Orange and Santa Clara — and the city of Oakland went to trial in April in a case alleging four drugmakers were complicit in the U.S. opioid epidemic through the use of deceptive marketing and soft-pedalling the painkillers’ addictive aspect. The plaintiffs contend the chains’ stores in the two counties bought a combined total of nearly 130 million oxycodone and hydrocodone pills — the most frequently diverted and abused painkillers — between 2000 and 2014.



How are states spending their opioid settlement cash? Look yours up in this database












CVS and Walgreens agree to pay $10 billion to settle lawsuits linked to opioid sales











CVS, Walgreens and Walmart ordered to pay $650 million for fueling opioid crisis




Discover Related

Glenmark to pay USD 7 mn to settle lawsuits with three entities in U.S.

What a $2 million per dose gene therapy reveals about drug pricing

City pays $28M to settle claims cops shielded serial rapist

Nearly four in five people want to get more treatments at pharmacies

'Sky-high price': The drug that costs $2M a dose

Purdue Pharma agrees to pay billions to settle OxyContin opioid crisis impact lawsuit

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic

Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations

Medicare targets 15 more drugs for price negotiations — including Ozempic

He went in for a colonoscopy. The hospital charged $19K for two.

Taxpayers paid $121M to settle complaints against New Jersey in 2023

Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probe

McKinsey & Company to pay $650 million for role in opioid crisis

Ohio Supreme Court sides with pharmacies in appeal of $650 million opioid judgment

Democrats can still pull off a victory before year's end: Lowering drug costs once more

Instead of sodas, these vending machines offer needles and Narcan to fight overdoses

Walmart reaches settlement deal for shareholder lawsuits over its handling of opioids

Women settle lawsuits after Yale fertility nurse switched painkiller for saline

Mississippi sues drugmakers and pharmacy benefit managers over opioids

The Fight for Drug Pricing Transparency

Medicare Price Negotiations Have Led To Agreements On 10 Drugs

Medicare negotiated drug prices for the first time. Here’s what it got
